PD-L1 expression in nonclear-cell renal cell carcinoma
Choueiri, T.K., Fay, A.P., Gray, K.P., Callea, M., Ho, T.H., Albiges, L., Bellmunt, J., Song, J., Carvo, I., Lampron, M., Stanton, M.L., Hodi, F.S., McDermott, D.F., Atkins, M.B., Freeman, G.J., Hirsch, M.S., Signoretti, S.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
Choueiri, T.K., Pal, S.K., McDermott, D.F., Morrissey, S., Ferguson, K.C., Holland, J., Kaelin, W.G., Dutcher, J.P.
Published in Annals of oncology (01.08.2014)
Published in Annals of oncology (01.08.2014)
Get full text
Journal Article
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Choueiri, T.K., Motzer, R.J., Rini, B.I., Haanen, J., Campbell, M.T., Venugopal, B., Kollmannsberger, C., Gravis-Mescam, G., Uemura, M., Lee, J.L., Grimm, M.-O., Gurney, H., Schmidinger, M., Larkin, J., Atkins, M.B., Pal, S.K., Wang, J., Mariani, M., Krishnaswami, S., Cislo, P., Chudnovsky, A., Fowst, C., Huang, B., di Pietro, A., Albiges, L.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Ghatalia, P, Je, Y, Kaymakcalan, M D, Sonpavde, G, Choueiri, T K
Published in British journal of cancer (20.01.2015)
Published in British journal of cancer (20.01.2015)
Get full text
Journal Article
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
Bellmunt, J., Fougeray, R., Rosenberg, J.E., von der Maase, H., Schutz, F.A., Salhi, Y., Culine, S., Choueiri, T.K.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Fradet, Y., Bellmunt, J., Vaughn, D.J., Lee, J.L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Nam, K., Frenkl, T.L., Perini, R.F., de Wit, R., Bajorin, D.F.
Published in Annals of oncology (01.06.2019)
Published in Annals of oncology (01.06.2019)
Get full text
Journal Article
Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma
Bellmunt, J., Mullane, S.A., Werner, L., Fay, A.P., Callea, M., Leow, J.J., Taplin, M.E., Choueiri, T.K., Hodi, F.S., Freeman, G.J., Signoretti, S.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
Heng, D.Y.C., Choueiri, T.K., Rini, B.I., Lee, J., Yuasa, T., Pal, S.K., Srinivas, S., Bjarnason, G.A., Knox, J.J., MacKenzie, M., Vaishampayan, U.N., Tan, M.H., Rha, S.Y., Donskov, F., Agarwal, N., Kollmannsberger, C., North, S., Wood, L.A.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
McGregor, B A, Sonpavde, G P, Kwak, L, Regan, M M, Gao, X, Hvidsten, H, Mantia, C M, Wei, X X, Berchuck, J E, Berg, S A, Ravi, P K, Michaelson, M D, Choueiri, T K, Bellmunt, J
Published in Annals of oncology (01.01.2024)
Published in Annals of oncology (01.01.2024)
Get full text
Journal Article
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
Heng, D.Y., MacKenzie, M.J., Vaishampayan, U.N., Bjarnason, G.A., Knox, J.J., Tan, M.H., Wood, L., Wang, Y., Kollmannsberger, C., North, S., Donskov, F., Rini, B.I., Choueiri, T.K.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
KO, J. J, CHOUEIRI, T. K, WOOD, L, VAISHAMPAYAN, U. N, AGARWAL, N, PAL, S. K, TAN, M.-H, RHA, S. Y, YUASA, T, DONSKOV, F, BAMIAS, A, HENG, D. Y. C, RINI, B. I, LEE, J.-L, KROEGER, N, SRINIVAS, S, HARSHMAN, L. C, KNOX, J. J, BJARNASON, G. A, MACKENZIE, M. J
Published in British journal of cancer (15.04.2014)
Published in British journal of cancer (15.04.2014)
Get full text
Journal Article
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy
Baz, R, Walker, E, Karam, MA, Choueiri, TK, Jawde, RA, Bruening, K, Reed, J, Faiman, B, Ellis, Y, Brand, C, Srkalovic, G, Andresen, S, Knight, R, Zeldis, J, Hussein, MA
Published in Annals of oncology (01.12.2006)
Published in Annals of oncology (01.12.2006)
Get full text
Journal Article
Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
KAYMAKCALAN, M. D, JE, Y, SONPAVDE, G, GALSKY, M, NGUYEN, P. L, HENG, D. Y. C, RICHARDS, C. J, CHOUEIRI, T. K
Published in British journal of cancer (25.06.2013)
Published in British journal of cancer (25.06.2013)
Get full text
Journal Article
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
Mahal, B.A., Chen, Y.-W., Muralidhar, V., Mahal, A.R., Choueiri, T.K., Hoffman, K.E., Hu, J.C., Sweeney, C.J., Yu, J.B., Feng, F.Y., Kim, S.P., Beard, C.J., Martin, N.E., Trinh, Q.-D., Nguyen, P.L.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
WANG, Y, CHOUEIRI, T. K, LEE, J.-L, TAN, M.-H, RHA, S. Y, NORTH, S. A, KOLLMANNSBERGER, C. K, McDERMOTT, D. F, HENG, D. Y. C
Published in British journal of cancer (18.03.2014)
Published in British journal of cancer (18.03.2014)
Get full text
Journal Article
Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors
Choueiri, T.K., Je, Y., Sonpavde, G., Richards, C.J., Galsky, M.D., Nguyen, P.L., Schutz, F., Heng, D.Y., Kaymakcalan, M.D.
Published in Annals of oncology (01.08.2013)
Published in Annals of oncology (01.08.2013)
Get full text
Journal Article
Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer
Yang, D.D., Krasnova, A., Nead, K.T., Choueiri, T.K., Hu, J.C., Hoffman, K.E., Yu, J.B., Spratt, D.E., Feng, F.Y., Trinh, Q.-D., Nguyen, P.L.
Published in Annals of oncology (01.02.2018)
Published in Annals of oncology (01.02.2018)
Get full text
Journal Article
JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)
Motzer, R.J., Penkov, K., Haanen, J.B.A.G., Rini, B.I., Albiges, L., Campbell, M.T., Kollmannsberger, C.K., Negrier, S., Uemura, M., Lee, J.L., Gurney, H., Berger, R., Schmidinger, M., Larkin, J., Atkins, M.B., Wang, J., Robbins, P.B., Chudnovsky, A., Di Pietro, A., Choueiri, T.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article